STOCK TITAN

Insider plans Rule 144 sale of 7,412 SNDX shares on NASDAQ

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder filed a notice of proposed sale under Rule 144 to sell 7,412 shares of common stock through Fidelity Brokerage Services LLC on or about 02/06/2026 on the NASDAQ. The filing reports an aggregate market value of $152,836.18 for these securities, compared with 86,914,838 shares outstanding for the issuer. The shares to be sold were acquired on 02/05/2026 via restricted stock vesting from the issuer as compensation, with payment also dated 02/05/2026. The signer represents they are not aware of undisclosed material adverse information about the issuer’s operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for SNDX disclose?

The Form 144 discloses a planned sale of 7,412 common shares of the issuer’s stock. The shares have an aggregate market value of $152,836.18 and are proposed to be sold on the NASDAQ through Fidelity Brokerage Services.

How many SNDX shares are planned to be sold under this Rule 144 notice?

The notice covers a proposed sale of 7,412 shares of common stock. These shares were recently acquired through restricted stock vesting as compensation and are being registered for potential sale in a single block through a brokerage firm.

What is the aggregate market value of the SNDX shares in this Form 144?

The filing states an aggregate market value of $152,836.18 for the 7,412 common shares to be sold. This value reflects the market price used in the Form 144 calculation for the proposed NASDAQ sale through Fidelity Brokerage Services LLC.

How were the SNDX shares in this Form 144 acquired?

The shares were acquired on 02/05/2026 through restricted stock vesting from the issuer as compensation. The same date is listed as the payment date, indicating they were granted rather than purchased for cash at the time of acquisition.

What does the Form 144 say about SNDX shares outstanding?

The filing reports that the issuer has 86,914,838 shares of common stock outstanding. This figure provides context for the 7,412 shares covered by the notice, showing the relative size of the proposed sale against the total outstanding shares.

Which broker and exchange are involved in this SNDX Form 144 sale?

The proposed sale will be handled by Fidelity Brokerage Services LLC and executed on the NASDAQ exchange. The Form 144 lists Fidelity’s Smithfield, Rhode Island address as the broker’s location for processing the transaction.
Syndax Pharmaceuticals Inc

NASDAQ:SNDX

View SNDX Stock Overview

SNDX Rankings

SNDX Latest News

SNDX Latest SEC Filings

SNDX Stock Data

2.12B
86.32M
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW YORK